Skip to main content

We are thrilled to announce the Africa CDC ๐š๐ง๐ ๐ˆ๐๐ƒ ๐‚๐จ๐ฎ๐ซ๐ฌ๐ž ๐“๐ซ๐š๐ข๐ง๐ข๐ง๐  ๐ข๐ง ๐•๐š๐œ๐œ๐ข๐ง๐ž ๐Œ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ข๐ง๐ , taking place from ๐๐จ๐ฏ๐ž๐ฆ๐›๐ž๐ซ ๐Ÿ๐Ÿ๐ญ๐ก ๐ญ๐จ ๐๐จ๐ฏ๐ž๐ฆ๐›๐ž๐ซ ๐Ÿ๐Ÿ“๐ญ๐ก, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’ at CARE facility, Institut Pasteur de Dakar.

This short-course training is a key part of the African Unionโ€™s New Public Health Order initiative, aimed at localizing vaccine manufacturing across the continent. In collaboration with Africa CDC, Nibrt and Institut Pasteur Dakar, we are enhancing biopharmaceutical capacity in Africa through practical training, contributing to the ambitious goal of achieving ๐Ÿ”๐ŸŽ% ๐ฅ๐จ๐œ๐š๐ฅ ๐ฏ๐š๐œ๐œ๐ข๐ง๐ž ๐ฆ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ข๐ง๐  ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ’๐ŸŽ and creating a qualified workforce.

We will select ๐Ÿ๐ŸŽ ๐œ๐š๐ง๐๐ข๐๐š๐ญ๐ž๐ฌ ๐Ÿ๐ซ๐จ๐ฆ ๐€๐Ÿ๐ซ๐ข๐œ๐š๐ง ๐”๐ง๐ข๐จ๐ง ๐Œ๐ž๐ฆ๐›๐ž๐ซ ๐’๐ญ๐š๐ญ๐ž๐ฌ, focusing on professionals from government agencies, NGOs, pharmaceutical companies, and research institutions involved in vaccine manufacturing.

๐Š๐ž๐ฒ ๐Œ๐จ๐๐ฎ๐ฅ๐ž๐ฌ ๐ˆ๐ง๐œ๐ฅ๐ฎ๐๐ž :

  • Introduction to Vaccines and Immunity
  • Biomanufacturing Process
  • Good Manufacturing Practices (GMP)
  • Facility and Contamination Control
  • Commissioning, Qualification, and Validation (CQV)

Join us in this transformative journey to enhace Africa’s public health landscape.
Register here: https://lnkd.in/eaHXtceJ